Merve Setenay Akyüzlüer Güneş

Prescribing patterns of vitamin and cofactor therapies in genetically confirmed primary mitochondrial diseases.

Despite advances in molecular diagnosis, empirical vitamin and cofactor supplementation remains frequently used in patients with PMDs who lack established gene- or pathway-specific therapeutic options, and this findings underscore the persistent gap between molecular diagnosis and evidence-based therapy.